Cargando…
Tumor necrosis factor-alpha and Fas/Fas ligand signaling pathways in chronic spontaneous urticaria
BACKGROUND: There is increasing evidence pointing to the important role of tumor necrosis factor-alpha (TNF-α), a key inflammatory and apoptotic mediator in urticarial inflammation. However, the role of the TNF-α system and Fas/Fas ligand (FasL) in the apoptosis-inducing pathways in chronic spontane...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417283/ https://www.ncbi.nlm.nih.gov/pubmed/30911316 http://dx.doi.org/10.1186/s13223-019-0332-7 |
_version_ | 1783403538817220608 |
---|---|
author | Grzanka, R. Damasiewicz-Bodzek, A. Kasperska-Zajac, A. |
author_facet | Grzanka, R. Damasiewicz-Bodzek, A. Kasperska-Zajac, A. |
author_sort | Grzanka, R. |
collection | PubMed |
description | BACKGROUND: There is increasing evidence pointing to the important role of tumor necrosis factor-alpha (TNF-α), a key inflammatory and apoptotic mediator in urticarial inflammation. However, the role of the TNF-α system and Fas/Fas ligand (FasL) in the apoptosis-inducing pathways in chronic spontaneous urticaria (CSU), remain unclear. AIM: To determine circulating concentrations of TNF-α, soluble TNF-α receptor type 1 and type 2 (sTNF-R1 and sTNF-R2, respectively) as well as soluble Fas (sFas) and FasL (sFasL) in CSU subjects. METHODS: Serum TNF-α, sTNF-R1, sTNF-R2, sFas, sFasL concentrations were measured using enzyme-linked immunosorbent assay in CSU subjects and in the healthy subjects. RESULTS: TNF-α concentrations were significantly higher in CSU subjects and moderate-to-severe CSU than in the controls, while there were no significant differences in TNF-α concentrations between subjects with mild CSU and the controls. sTNF-R1 and sTNF-R2 concentrations were significantly higher in all CSU and moderate-severe CSU subjects vs. the controls. Serum concentrations were also significantly higher in mild CSU vs. the controls, but not in moderate-severe CSU vs. mild CSU. No significant differences were observed in sFas and sFasL concentrations between CSU subjects and the healthy controls. Significant correlations were found between concentrations of TNF-α and its receptors, as well as sTNF-R1 and sTNF-R2, but not with the urticaria activity score (UAS). There was no relationship between TNF-α/sTNF-R1/sTNF-R2 and sFas/sFasL pathways in CSU. CONCLUSIONS: CSU is associated with the activation of the TNF-α/receptors signaling pathway, marked by increased circulating concentrations of TNF-α, sTNF-R1 and sTNF-R2, which are related to each other in this disease. In contrast, the circulating sFas/FasL system is not up-regulated in CSU, and sFas/sFasL may not be a useful marker of the activity/severity of urticarial processes. Considering the lack of significant changes in sFas/sFasL (mainly reflecting systemic apoptosis) in CSU patients, it appears that elevated serum TNF-α concentrations are related to its pro-inflammatory function rather than an enhanced systemic apoptotic response in CSU. |
format | Online Article Text |
id | pubmed-6417283 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-64172832019-03-25 Tumor necrosis factor-alpha and Fas/Fas ligand signaling pathways in chronic spontaneous urticaria Grzanka, R. Damasiewicz-Bodzek, A. Kasperska-Zajac, A. Allergy Asthma Clin Immunol Research BACKGROUND: There is increasing evidence pointing to the important role of tumor necrosis factor-alpha (TNF-α), a key inflammatory and apoptotic mediator in urticarial inflammation. However, the role of the TNF-α system and Fas/Fas ligand (FasL) in the apoptosis-inducing pathways in chronic spontaneous urticaria (CSU), remain unclear. AIM: To determine circulating concentrations of TNF-α, soluble TNF-α receptor type 1 and type 2 (sTNF-R1 and sTNF-R2, respectively) as well as soluble Fas (sFas) and FasL (sFasL) in CSU subjects. METHODS: Serum TNF-α, sTNF-R1, sTNF-R2, sFas, sFasL concentrations were measured using enzyme-linked immunosorbent assay in CSU subjects and in the healthy subjects. RESULTS: TNF-α concentrations were significantly higher in CSU subjects and moderate-to-severe CSU than in the controls, while there were no significant differences in TNF-α concentrations between subjects with mild CSU and the controls. sTNF-R1 and sTNF-R2 concentrations were significantly higher in all CSU and moderate-severe CSU subjects vs. the controls. Serum concentrations were also significantly higher in mild CSU vs. the controls, but not in moderate-severe CSU vs. mild CSU. No significant differences were observed in sFas and sFasL concentrations between CSU subjects and the healthy controls. Significant correlations were found between concentrations of TNF-α and its receptors, as well as sTNF-R1 and sTNF-R2, but not with the urticaria activity score (UAS). There was no relationship between TNF-α/sTNF-R1/sTNF-R2 and sFas/sFasL pathways in CSU. CONCLUSIONS: CSU is associated with the activation of the TNF-α/receptors signaling pathway, marked by increased circulating concentrations of TNF-α, sTNF-R1 and sTNF-R2, which are related to each other in this disease. In contrast, the circulating sFas/FasL system is not up-regulated in CSU, and sFas/sFasL may not be a useful marker of the activity/severity of urticarial processes. Considering the lack of significant changes in sFas/sFasL (mainly reflecting systemic apoptosis) in CSU patients, it appears that elevated serum TNF-α concentrations are related to its pro-inflammatory function rather than an enhanced systemic apoptotic response in CSU. BioMed Central 2019-03-14 /pmc/articles/PMC6417283/ /pubmed/30911316 http://dx.doi.org/10.1186/s13223-019-0332-7 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Grzanka, R. Damasiewicz-Bodzek, A. Kasperska-Zajac, A. Tumor necrosis factor-alpha and Fas/Fas ligand signaling pathways in chronic spontaneous urticaria |
title | Tumor necrosis factor-alpha and Fas/Fas ligand signaling pathways in chronic spontaneous urticaria |
title_full | Tumor necrosis factor-alpha and Fas/Fas ligand signaling pathways in chronic spontaneous urticaria |
title_fullStr | Tumor necrosis factor-alpha and Fas/Fas ligand signaling pathways in chronic spontaneous urticaria |
title_full_unstemmed | Tumor necrosis factor-alpha and Fas/Fas ligand signaling pathways in chronic spontaneous urticaria |
title_short | Tumor necrosis factor-alpha and Fas/Fas ligand signaling pathways in chronic spontaneous urticaria |
title_sort | tumor necrosis factor-alpha and fas/fas ligand signaling pathways in chronic spontaneous urticaria |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417283/ https://www.ncbi.nlm.nih.gov/pubmed/30911316 http://dx.doi.org/10.1186/s13223-019-0332-7 |
work_keys_str_mv | AT grzankar tumornecrosisfactoralphaandfasfasligandsignalingpathwaysinchronicspontaneousurticaria AT damasiewiczbodzeka tumornecrosisfactoralphaandfasfasligandsignalingpathwaysinchronicspontaneousurticaria AT kasperskazajaca tumornecrosisfactoralphaandfasfasligandsignalingpathwaysinchronicspontaneousurticaria |